COVID-19-Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study

• by Zahra Ghavami, Mahboubeh Haddad, Fereshte Sheybani, Matin Shirazinia, Maliheh Dadgar Moghadam

• November 3, 2025

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

• by Kathryn Wighton

• May 12, 2026

• 2 min

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

• by Jiazi Tian, Alaleh Azhir, Matthew Decaro, Ngan Chau, Jonas Hügel, Michele Morris, Jingya Cheng, Pedram Fard, Ingrid V. Bassett, Douglas S. Bell, Elmer V. Bernstam, Shyam Visweswaran, Jeffrey G. Klann, Shawn N. Murphy, Hossein Estiri

• May 27, 2026

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

• by Shirkhan Amikishiyev, Rabia Deniz, Mehmet Guven Gunver, Sarvan Aghamuradov, Nevzat Koca, Burak Ince, Murat Bektas, Aysenur Yilmaz, Yagmur Canturk, Gorkem Durak, Murat Kose, Mustafa Erelel, Arif Atahan Çağatay, Serap Simsek Yavuz, Sevgi Kalayoglu Besisik, Figen Esen, Ahmet Gül

• May 22, 2026